Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2024-03-18 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs the stock exchanges about the receipt of an Assessment Order and Demand Notice from the Income Tax Department for the fiscal year 2015-16. The document includes details of the order, the nature of the tax demand, and the company's response. It is a regulatory announcement about a legal/tax matter rather than a full report or financial statement. The document length is 3164 characters, which is relatively short and consistent with a regulatory filing or announcement. There is no detailed financial data or comprehensive report content. Therefore, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-03-18 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal announcement from Dr. Lal PathLabs Limited regarding the appointment and re-designation of Mr. Shankha Banerjee as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP). It references compliance with SEBI Listing Regulations and provides details about the appointment, effective date, and brief profile of the appointee. There are no financial statements, earnings data, or detailed management discussion of financial results. The document is a regulatory disclosure about a management change, specifically the appointment of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4548 characters, which is consistent with a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2024-03-17 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal announcement from Dr. Lal PathLabs Limited regarding the appointment and re-designation of Mr. Shankha Banerjee as Chief Executive Officer (Key Managerial Personnel). It references compliance with SEBI Listing Regulations and provides details about the appointment, effective date, and brief profile of the appointee. There are no financial statements, earnings data, or detailed management discussion of financial results. The document is a regulatory disclosure about a management change, specifically the appointment of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4548 characters, which is consistent with a detailed announcement but not a full report.
2024-03-17 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal announcement from Dr. Lal PathLabs Limited regarding the appointment and re-designation of Mr. Shankha Banerjee as Chief Executive Officer (Key Managerial Personnel). It references compliance with SEBI Listing Regulations and provides details about the appointment, effective date, and brief profile of the appointee. There are no financial statements, earnings data, or detailed management discussion of financial results. The document is a regulatory disclosure about a management change, specifically the appointment of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4548 characters, which is consistent with a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2024-03-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 13, 2024, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of upcoming investor meetings, specifically a group conference call scheduled for March 19, 2024. There is no financial data, report, or detailed presentation included, only an intimation of the schedule. The document length is 1763 characters, which is short and fits the pattern of an announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2024-03-13 English
Resignation
Regulatory Filings
2024-03-03 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.